| 順位 | 説明 |
|
1位
¥12,154円
評価: 0
|
楽天Kobo電子書籍ストア
＜p＞This volume provides a practical yet comprehensive guide to manage the shift in the diagnosis of lung cancer from large resections to small samples, including cytology specimens and core biopsies. Specifically, it outlines various available minimally-invasive modalities and presents algorithms to optimize and maximize sample collection and processing beginning at the time of tissue acquisition during the procedure. Secondly, the book provides an overview of the various existing and emerging lung cancer therapies and why a specific diagnosis is crucial. Key elements for the classification of small biopsies and cytology proposed by the ATS, IASLC, and ERS are highlighted. A section dedicated to immunohistochemistry offers a logical, step-by-step guide to sub-classify lung cancers and to differentiate them from metastases. The text also provides a review of the various molecular tests (and alternatives in cases of scant tissue) required for lung adenocarcinomas. Finally, potential pitfalls to avoid during acquisition, processing, and classification are discussed.＜/p＞ ＜p＞With contributions from a team of multidisciplinary authors who are regularly involved in the care of lung cancer patients , ＜em＞Diagnosing Non-small Cell Carcinoma in Small Biopsy and Cytology＜/em＞ is an invaluable reference guide for pathologists, pathologists-in-training, and allied professionals, including oncologists, pulmonologists, surgeons, and radiologists.＜/p＞画面が切り替わりますので、しばらくお待ち下さい。 ※ご購入は、楽天kobo商品ページからお願いします。※切り替わらない場合は、こちら をクリックして下さい。 ※このページからは注文できません。
|
|
2位
¥3,392円
評価: 0
|
楽天Kobo電子書籍ストア
＜p＞In the future there will be two groups of cancer patients. Those who have read this book - and those who are uninformed. For many years Lothar Hirneise has been traveling throughout the world looking for the most successful cancer therapies, and he has been explaining to people that there is much more available than just chemotherapy and irradiation. Recognized internationally as Europe's leading specialist in this area, he describes the results of his years of research in this encyclopedia of non-conventional therapies. The reader will also learn in detail why so-called experts in reality know little about cancer. In addition to descriptions of more than 100 cancer therapies and substances used in treating cancer, the author also explains which cancer therapies are used allopathically, for which types of cancer, and what is imperative for a patient to know before he subjects himself to such therapies. The 3E program, which is based on the analysis of case histories of thousands of people who have survived late stage cancer, is also described for the first time. Learn why so many people die of cancer, and why so many others do not. This book not only supplies an incredible amount of information, it also helps the cancer patient to find his own way to cure cancer through the active exercises of the 3E program.＜/p＞画面が切り替わりますので、しばらくお待ち下さい。 ※ご購入は、楽天kobo商品ページからお願いします。※切り替わらない場合は、こちら をクリックして下さい。 ※このページからは注文できません。
|
|
3位
¥3,395円
評価: 0
|
楽天Kobo電子書籍ストア
＜p＞In the future there will be two groups of cancer patients. Those who have read this book - and those who are uninformed. For many years Lothar Hirneise has been traveling throughout the world looking for the most successful cancer therapies, and he has been explaining to people that there is much more available than just chemotherapy and irradiation. Recognized internationally as Europe's leading specialist in this area, he describes the results of his years of research in this encyclopedia of non-conventional therapies. The reader will also learn in detail why so-called experts in reality know little about cancer. In addition to descriptions of more than 100 cancer therapies and substances used in treating cancer, the author also explains which cancer therapies are used allopathically, for which types of cancer, and what is imperative for a patient to know before he subjects himself to such therapies. The 3E program, which is based on the analysis of case histories of thousands of people who have survived late stage cancer, is also described for the first time. Learn why so many people die of cancer, and why so many others do not. This book not only supplies an incredible amount of information, it also helps the cancer patient to find his own way to cure cancer through the active exercises of the 3E program.＜/p＞画面が切り替わりますので、しばらくお待ち下さい。 ※ご購入は、楽天kobo商品ページからお願いします。※切り替わらない場合は、こちら をクリックして下さい。 ※このページからは注文できません。
|
|
4位
¥12,154円
評価: 0
|
楽天Kobo電子書籍ストア
＜p＞This book provides a comprehensive guide to the treatment of small hepatocellular carcinoma (sHCC) using a minimally invasive technique: radiofrequency ablation (RFA). RFA has emerged as a new treatment modality and become the main modality of locoregional therapy. Extensive clinical research indicates that RFA is as effective as surgical resection for sHCC, and it has the advantage of being less invasive. However, the outcomes after RFA are largely dependent on the operators’ experience- known as the “learning curve”. This book presents the characteristics of sHCC and discusses why sHCC is the best candidate for RFA. Then it introduces all the commercially available RFA systems, and their working principles, advantages, disadvantages and so on. It goes on to demonstrate how to perform RFA under the guidance of ultrasound, CT, laparoscopy, or during open operation. Finally, it discusses the radiologic assessment and followーup after RFA, as well as adjuvant therapies and clinical trials on RFA. The authors are experts from the fields of pathology, radiology, surgery, and gastroenterology, as well as manufacturers. With this book, readers gain have a clear idea of when and how to do RFA. It aims to standardize and generalize the procedure of RFA, which will be very helpful in improving the outcome of RFA for sHCC.＜/p＞画面が切り替わりますので、しばらくお待ち下さい。 ※ご購入は、楽天kobo商品ページからお願いします。※切り替わらない場合は、こちら をクリックして下さい。 ※このページからは注文できません。
|